• Elixxer (ELXR) is pleased to welcome Mr. Jeremy Green to the corporation’s board of directors
  • Mr. Green’s career spans over twenty years in the banking industry, including a role as a senior director for online and mobile banking with a major Canadian chartered bank
  • Mr. Green has been a leading speaker on digital banking strategies at numerous industry conferences
  • He holds a bachelor’s degree in administration from Simon Fraser University and an MBA in finance from Wilfrid Laurier University
  • Elixxer Ltd is a Canadian-based company engaged in growing and producing medical-grade cannabis
  • Elixxer Ltd. (ELXR) is unchanged, trading at C$0.015 per share at 12:45 pm EST

Elixxer (ELXR) is pleased to welcome Mr. Jeremy Green to the corporation’s board of directors. 

Mr. Green’s career spans over twenty years in the banking industry. Until recently, he was senior director for online and mobile banking with a major Canadian chartered bank. Prior to that, he spent ten years with a competing Canadian chartered bank where he worked on numerous large scale retail banking projects, both in North America and in Europe.

Mr. Green has been a leading speaker on digital banking strategies at numerous industry conferences. He holds a bachelor’s degree in administration from Simon Fraser University and an MBA in finance from Wilfrid Laurier University.

Mr. Green’s appointment is subject to acceptance by the TSX Venture Exchange.

Elixxer Ltd is a Canadian-based company engaged in growing and producing medical-grade cannabis.

Elixxer Ltd. (ELXR) is unchanged, trading at C$0.015 per share at 12:45 pm EST.

More From The Market Online

The Market Online’s Weekly Cannabis Report – April 19, 2024

Cannabis news this week: Canopy Growth shareholders overwhelmingly voted to approve a new class of exchangeable shares.

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.

Canadian biotech stock investigates potential weight loss drugs

FSD Pharma Inc. (CSE:HUGE) is expanding its pipeline into metabolic and related disorders including weight loss and liver health.

Xebra Brands receives second CBD approval by Mexican authority

Xebra Brands (CSE:XBRA) announces it has received its second COFEPRIS approval for CBD product authorization in Mexico.